Previous Close | 0.476 |
1-Year Change | -76.49% |
6-Months Change | 4.62% |
3-Months Change | 55.05% |
Moving Avg (50d) | 0.4656 |
Moving Avg (200d) | 0.6637 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 46.8M |
Beta (3-Years) | 1.51 |
Revenue Growth (ttm) | 26.09% |
Net Profit Margin (ttm) | -189.81% |
Return On Assets (ttm) | -63.89% |
EPS (ttm) | -3.07 |
PE Ratio (ttm) | -0.16 |
Dividend Yield | % |
Asset Description: | FibroGen, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-22 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.486 | 0.5 | 0.509 | 0.524 | 0.547 | 0.571 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.